Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer India has announced that its board has cleared the proposal for the transfer of licenses of Listerine, Benadryl, Caladryl and Benylin brands to Johnson & Johnson for $55 million.
Subscribe to our email newsletter
The license includes trademarks and a few assets of the products. The company said that the other brands and consumer health team will continue to be part of the company.
Kewal Handa, managing director of Pfizer India, said: “Our consumer health portfolio includes key brands such as Gelusil, Nebasulf, Selsun, Ferradol, Neko and Waterbury’s Compound. We believe there is tremendous potential in our brands, and business strategies will be put in place to maximize opportunities and drive growth in the consumer health business.”